Guide to the correct consumption and medication of Anamorelin

Anamorelin(Anamorelin) is an oral small molecule drug, and its efficacy is closely related to the correct way of taking it. Overseas instructions and clinical practice experience emphasize that standardized medication is an important prerequisite for achieving stable effects, especially among people with cachexia who are highly sensitive to physical conditions.

From the recommended usage point of view, the conventional dosage of anamulin is 100 mg per time taken orally once a day. This dose design is based on the comprehensive evaluation of efficacy and tolerability in multiple overseas studies. It can effectively activate ghrelin receptors while maintaining good safety. During use, patients should try to take the medicine at a fixed time every day to reduce fluctuations in drug concentration in the body and facilitate continued effects.

In terms of timing of taking, Anamorelin is generally recommended to be taken on an empty stomach. This is because in a fasting state, drug absorption is more stable, which helps it to fully exert its physiological regulatory effect in the body. It is generally recommended to take it before breakfast or between meals, and avoid taking it at the same time as high-fat meals to avoid affecting absorption efficiency. When taking the medicine, you can swallow the tablet whole with an appropriate amount of warm water. It is not recommended to crush or chew it to avoid affecting the structure and absorption characteristics of the medicine.

During the medication process, patients and their families should establish reasonable expectations. Anamorelin is not a strong stimulant drug that has "immediate effect". Its effect often manifests gradually after being taken continuously for a period of time. Some patients experience an improvement in appetite early on, but changes in weight, muscle strength, and quality of life usually require longer observation. Therefore, the drug should not be discontinued or the dose adjusted in the short term due to lack of obvious effects.

In addition, although anamorelin is generally well tolerated, during long-term use, regular follow-up is still recommended to pay attention to the overall nutritional status, metabolic indicators, and concomitant medications. Especially for patients receiving anti-tumor therapy at the same time, the timing and duration of medication should be evaluated under the guidance of a doctor.

Reference materials:https://pins.japic.or.jp/pdf/newPINS/00069223.pdf